Thalassemia Market Size, A Comprehensive Outlook and Forecast for 2026-2035
The global thalassemia market was valued at USD 995.7 million in 2025 and is projected to reach USD 2,023.8 million by the end of 2035, expanding at a CAGR of 7.8% during the forecast period (2026–2035). The market is experiencing notable growth due to increasing awareness of inherited blood disorders, advancements in genetic therapies, expanding screening programs, and improved access to treatment options. Rising investments in rare disease research and the introduction of innovative therapeutic approaches are further supporting market expansion worldwide.
